BridgeMD
Tests treatment safety and results for Trigger Finger
Official title Efficacy of Ultrasound-Guided Needle Knife Release for Trigger Finger
ClinicalTrials.gov ID: NCT06788860
What this study is testing
- What it's testing
- Efficacy of ultrasound-guided tri-directional needle knife release in treating patients with trigger finger. The study evaluates safety, effectiveness, and recovery outcomes of a minimally invasive procedure compared to conventional approaches.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Idiopathic TF at the level of A1 pulley
- Trigger finger of Green's grades II or III or IV (moderate to severe)
- Symptoms persist for at least three months despite conservative treatments.
- Ability to provide informed consent and comply with follow-up requirements.
You likely can't join if
- Patients with secondary causes of TF like diabetes mellitus, rheumatoid arthritis, gout, hypothyroidism, amyloidosis, and sarcoidosis.
- Patients with TF of Green's grade I.
- Previous surgical intervention on the affected digit.
- Allergy or contraindication to local anesthetics.
- Pregnancy or lactation.
- Inability to comply with follow-up assessments.
The study team makes the final eligibility decision.
Where it's taking place
- Al Mansurah, Dakahlia Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Al Mansurah, Dakahlia Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.